22408257Warlick E, Ahn KW, Pedersen TL, Artz A, de Lima M, Pulsipher M, Akpek G, Aljurf M, Cahn JY, Cairo M, Chen YB, Cooper B, Deol A, Giralt S, Gupta V, Khoury HJ, Kohrt H, Lazarus HM, Lewis I, Olsson R, Pidala J, Savani BN, Seftel M, Soci? G, Tallman M, Ustun C, Vij R, Vindel?v L, Weisdorf DBloodGraft vs Host Disease; Hematopoietic Stem Cell Transplantation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Recurrence, Local; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Transplantation ConditioningAdult; Aged; Benzamides; Female; Humans; Imatinib Mesylate; Male; Middle Aged; Protein Kinase Inhibitors; Survival Rate; Transplantation, Homologous; Unrelated DonorsReduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era. Blood. 2012 Apr 26; 119(17):4083-90.Blood2012-03-09T00:00:002012Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era.prns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAuthorshipvivo:hasSubjectAreahas subject areaInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedInformationResourcelinked information resourcerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptD047428Chemicals & Drugs31480.963145Protein Kinase InhibitorsD000368Living Beings46094410.373165AgedD015464Disorders790.996015Leukemia, Myelogenous, Chronic, BCR-ABL PositiveD001549Chemicals & Drugs13160.991329BenzamidesD011743Chemicals & Drugs17210.9914PyrimidinesD061349Living Beings140.998926Unrelated DonorsD019172Procedures11350.98887Transplantation ConditioningD008875Concepts & IdeasLiving Beings48498180.3737Middle AgedD006086Disorders18450.955315Graft vs Host DiseaseD009364Disorders591840.888931Neoplasm Recurrence, LocalD000328Living Beings51785940.393502AdultD008297Physiology565156330.299056MaleD014184Procedures602770.900049Transplantation, HomologousD005260Physiology580162050.293542FemaleD011505Chemicals & Drugs16210.992479Protein-Tyrosine KinasesD010879Chemicals & Drugs36900.920694PiperazinesAuthorship 206690.2168130.2168131authors10.2520has subject areaD015996Concepts & Ideas1003480.908732Survival RateD006801Living Beings644293510.211905HumansD000068877220.999758Imatinib MesylateD018380Procedures23890.912263Hematopoietic Stem Cell Transplantation